What is the Syn-Tech Chem. & Pharm. Co., Ltd. stock price forecast?

Syn-Tech Chem. & Pharm. Co., Ltd. is currently trading at $72.00. View real-time AI analysis on Alpha Lenz.

What is Syn-Tech Chem. & Pharm. Co., Ltd. insider trading activity?

View the latest insider trading data for Syn-Tech Chem. & Pharm. Co., Ltd. on Alpha Lenz.

What is Syn-Tech Chem. & Pharm. Co., Ltd.'s P/E ratio?

View Syn-Tech Chem. & Pharm. Co., Ltd.'s valuation metrics on Alpha Lenz.

Syn-Tech Chem. & Pharm. Co., Ltd.

TWSE · 1777

NT$72.00+0.10(+0.14%)

Ask about Syn-Tech Chem. & Pharm. Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Syn-Tech Chem. & Pharm. Co., Ltd.'s ROE is 10.2%. Explore profitability and growth together.”

Ask for details →

Company Overview

Syn-Tech Chem. & Pharm. Co., Ltd. is a pharmaceutical manufacturer specializing in the research, development, and production of active pharmaceutical ingredients. Founded in 1982 and headquartered in Tainan, Taiwan, the company plays a vital role in the health technology sector by supplying key pharmaceutical compounds used in the formulation of various medications. Its product portfolio encompasses local anesthetics, cardiovascular medications, muscle relaxants, respiratory system drugs, central nervous system agents, digestive and urinary system drugs, and topical preparations. Syn-Tech Chem. & Pharm. Co., Ltd. serves both domestic and international clients, contributing to the reliability and supply of essential pharmaceuticals for healthcare providers and the broader medical industry. With a commitment to innovation and quality control, the company supports the pharmaceutical supply chain’s integrity and advances public health outcomes in the markets it serves.

Websitehttps://www.syn-tech.com.tw

SectorHealthcare

IndustryBiotechnology

Employees227

Company Statistics

FY 2025

Profile

N/AMarket Cap

NT$1.30BRevenue

0.00Shares Out

227Employees

Margins

34.64%Gross

37.07%EBITDA

24.60%Operating

25.68%Pre-Tax

20.12%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

9.65%Rev 3Yr

5.74%Rev 5Yr

10.32%Op Inc 3Yr

4.04%Op Inc 5Yr

-3.96%Net Inc 3Yr

6.97%Net Inc 5Yr

Returns

9.00%ROA

10.16%ROE

11.53%ROIC

Financial Health

NT$1.05BCash & Cash Equivalents

NT$-679.03MNet Debt

14.27%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Syn-Tech Chem. & Pharm. Co., Ltd.'s ROE is 10.2%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Syn-Tech Chem. & Pharm. Co., Ltd. (ticker: 1777) is a company listed on TWSE in the Healthcare sector (Biotechnology). It has approximately 227 employees.

The current price is 72 with a P/E ratio of -x and P/B of -x.

ROE is 10.16% and operating margin is 24.60%. Annual revenue is $1.3B.